KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Gross Profit Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 54.44%
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 9.77%
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 15.45%
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -0.16%
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 13.38%
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 7.57%
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -65.16%
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -1.22%
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 9.77%
Dec 28, 2025 7.82%
Sep 28, 2025 7.62%
Jun 29, 2025 3.45%
Mar 30, 2025 -2.26%
Dec 29, 2024 5.45%
Sep 29, 2024 5.17%
Jun 30, 2024 3.46%
Mar 31, 2024 4.68%
Dec 31, 2023 5.36%
Oct 1, 2023 6.66%
Jul 2, 2023 8.38%
Apr 2, 2023 2.79%
Oct 2, 2022 -14.07%
Jul 3, 2022 -11.65%
Apr 3, 2022 -9.41%
Oct 3, 2021 14.02%
Jul 4, 2021 33.75%
Apr 4, 2021 11.95%
Jan 3, 2021 7.70%
Sep 27, 2020 1.79%
Jun 28, 2020 -13.69%
Mar 29, 2020 1.66%
Dec 29, 2019 1.34%
Sep 29, 2019 0.75%
Jun 30, 2019 -2.02%
Mar 31, 2019 0.08%
Dec 30, 2018 3.84%
Sep 30, 2018 8.13%
Jul 1, 2018 7.00%
Apr 1, 2018 8.40%
Dec 31, 2017 2.90%
Oct 1, 2017 3.17%
Jul 2, 2017 -1.16%
Apr 2, 2017 1.68%
Jan 1, 2017 3.58%
Oct 2, 2016 3.84%
Jul 3, 2016 5.76%
Apr 3, 2016 0.50%
Jan 3, 2016 -2.12%
Sep 27, 2015 -9.11%
Jun 28, 2015 -7.62%
Mar 29, 2015 -4.49%
Dec 28, 2014 0.01%
Sep 28, 2014 6.84%
Jun 29, 2014 8.62%
Mar 30, 2014 5.93%
Dec 29, 2013 7.31%
Sep 29, 2013 6.77%
Jun 30, 2013 9.32%
Mar 31, 2013 6.48%
Dec 30, 2012 5.84%
Sep 30, 2012 4.77%
Jul 1, 2012 -0.81%
Apr 1, 2012 -1.50%
Jan 1, 2012 2.95%
Oct 2, 2011 5.25%
Jul 3, 2011 6.78%
Apr 3, 2011 2.63%
Jan 2, 2011 -5.65%
Oct 3, 2010 -2.43%
Jul 4, 2010 -0.82%
Apr 4, 2010 3.04%